Professor Gupta will be primarily based in the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID). However, the role will also drive Cambridge’s work as part of the HKJC Global Health Institute (GHI).  

The GHI was formed in March 2024 based on a partnership between the University of Cambridge, Hong Kong University (HKU) and the International Vaccine Institute (IVI) in Seoul. 

The work of the GHI aims to prepare for future possibilities of pandemics, using international collaboration to achieve this. 

Professor Gupta, recognising the importance of this work, said: 

“The GHI will benefit from IVI’s expertise in vaccine development, HKU’s leadership in pandemic virology and epidemiology and CITIID’s strength in human immunology and virology. Together, it will unite world-leading scientists and research teams to foster collaboration and innovation in vaccine research”. 

Thanks to international academic collaboration and the generosity of the Hong Kong Jockey Club Charitable Trust, which made this endowed position possible, Professor Gupta will play a pioneering role in increasing global preparation for future pandemics.

The University is very grateful for the support of the Friends of Cambridge University in Hong Kong, especially its founding chairman, Dr Sir David Li, for its support in facilitating this important donation.